Lung Ultrasound-guided Hemodynamic Optimization

Status Recruiting

Clinical Trial Summary

The formalized expert recommendation of the French Society of Anesthesia and Intensive Care recommends guiding vascular filling by measuring the stroke volume (SV) in surgical patients considered at high risk. Vascular filling should be continued in the event of preload dependence and stopped in the event of the appearance of preload independence. The aim is to avoid vascular overload due to excessive vascular filling. The application of this recommendation has resulted in a reduction in postoperative morbidity, length of hospital stay and time to return to oral feeding. The superiority of this strategy is now being questioned and the predictive indices of response to vascular filling (static and dynamic) have many limitations. In addition, none of the cardiac output monitors are the gold standard for intraoperative use. Through the study of artefacts, lung ultrasound has been gaining ground over the last twenty years, particularly in cardiology, nephrology and intensive care. By analogy with radiological B-lines, ultrasound B-lines result from the reverberation of ultrasound on the subpleural inter-lobular septa thickened by oedema. The Fluid Administration Limited by Lung Sonography (FALLS) protocol, described by Lichtenstein et al, is defined as the visualisation of new B lines during a vascular filling test. If a B-line appears in an area where it was not present during vascular filling, the most likely diagnosis is hydrostatic overload of the subpleural interstitial septum. This appearance of B-lines occurs at a sub-clinical stage. The use of lung ultrasound could allow real-time assessment of vascular filling and its tolerance during the intraoperative period. The main objective of the study is to demonstrate a decrease in the incidence of postoperative complications (organ failure) (as defined by international guidelines) when using lung ultrasound-guided haemodynamic optimisation compared to standard optimisation.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05481723
Study type	Interventional
Source	Centre Hospitalier Universitaire, Amiens
Contact	Stéphane BAR, DR
Phone	03 22 08 79 06
Email	bar.stephane@chu-amiens.fr
Status	Recruiting
Phase	N/A
Start date	July 28, 2022
Completion date	August 2027

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04057625` - Transthoracic Ultrasound in the Diagnosis and Follow-up of Ventilator Associated Pneumonia	N/A
Terminated	`NCT02556853` - Ultrasound for Double Lumen Endotracheal Tube	N/A
Active, not recruiting	`NCT03546699` - Hospital-wide Incidence, Clinical Characteristics and Outcomes of ARDS
Recruiting	`NCT03619525` - Ultrasonographic Assessment of the Effect of CPB Acute Lung Injury	N/A
Completed	`NCT05132036` - Lung Ultrasound Assessment of Fluid Overload in Haemodialysis Patients	N/A
Not yet recruiting	`NCT04618627` - Role of Lung Ultrasonography in Prediction of the Seveity and the Need for Surfactant Administration in Neonates With Respiratory Distress Syndrome
Completed	`NCT04474236` - Lung Ultrasound for COVID-19 Initial Triage and Monitoring
Active, not recruiting	`NCT05035459` - B-lines-guided Heart Failure Management in Heart Failure Patients
Not yet recruiting	`NCT05272982` - Thoracic Fluid Content by Electrical Cardiometry Versus Lung Ultrasound in Mechanically Ventilated Patients
Recruiting	`NCT06307704` - Lung US for PEEP Optimization in Robotic Radical Prostatectomy or Cystectomy Patients	N/A
Not yet recruiting	`NCT06235645` - dEtection of rheumAtoid aRthritis - Interstitial Lung dIseasE by Thoracic ultRasound
Not yet recruiting	`NCT05261295` - Comparison of PEEP Effect on Perioperative Oxygenation and Postoperative Pulmonary Complications in Lithotomy Position
Completed	`NCT04719234` - Lung Ultrasonography in COVID-19 Pneumonia	N/A
Recruiting	`NCT05024942` - LUS in Aortic Stenosis Patients Undergoing TAVR
Completed	`NCT05706441` - Lung and Diaphragm Ultrasound Evaluation During Weaning From Mechanical Ventilation in COVID-19 Patients
Recruiting	`NCT05175313` - Transthoracic Ultrasonography Findings and Their Relation to Spirometric Indices in Patients With Obstructive and Restrictive Respiratory Diseases
Completed	`NCT04805684` - Different Lung Ultrasound Imaging Protocols in COVID-19 Pneumonia	N/A
Recruiting	`NCT06157138` - Observation of B-lines in Pulmonary Echography, During Open Abdominal Surgery
Completed	`NCT05171608` - Preoperative Ultrasound-based Protocol for Optimization of Fluid Therapy to Prevent Early Intraoperative Hypotension	N/A
Completed	`NCT04666064` - Validation of COVILUS Score in Patients Suspected of COVID-19 Infection in the Emergency Room

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Lung Ultrasound-guided Hemodynamic Optimization — POINTBAR

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms